Neulasta®

Neulasta is used to prevent neutropenia, a lack of certain white blood cells caused by receiving chemotherapy. Neulasta is indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia.

Neulasta® helps protect against the risk of infection and provides support through your chemotherapy cycle with just one injection. Neulasta® works like a natural protein within your body to signal the growth of new white blood cells, which helps protect against the risk of infection following chemotherapy.